Timelotem

This classification denotes an antipsychotic agent with the molecular formula C17H18FN3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 090DE9CRP1, chemically known as 1,2,3,4,4a,5-hexahydro-10-fluoro-3-methyl-7-(2-thienyl)pyrazino(1,2-a)(1,4)benzodiazepine but generally known as timelotem, which bears US NIH Compound Identifier 65844. European Medicines Agency schedules Timelotem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11063MIG. The term TIMELOTEM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). TIMELOTEM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule timelotem under HS 29349990 and SITC 51579. As of Q4 2014, TIMELOTEM remains the US FDA Preferred Term for this commodity. Timelotem bears US NLM identifiers UMLS ID C0076685 and NCI Concept Code C76450. SMILES: S1C(C2=NCC3N(CCN(C3)C)C3C2CCC(F)C3)CCC1.